Want to join the conversation?
Pharmaceutical giant $PFE said that it will acquire $ANAC, a biopharmaceutical company for $99.25 per $ANAC share, in cash, for a total transaction value, net of cash, of approx. $5.2Bil. $ANAC's flagship asset, crisaborole, a non-steroidal topical PDE4 inhibitor with anti-inflammatory properties, is currently under review by the FDA for eczema.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.
$RAI has received a $47 billion take over offer from British tobacco giant British American Tobacco! This is huge!
No better outlook on $MSFT. Even if the results beat a bit, the stock may move 4 to 6% higher, but won't go above $60.